logo

Saving patients from severe heart failure

Sector: Broadband • Location: France

Source: EU Funding & Tenders Portal

Project
Ended

The ICOMS FlowMaker® is the first intracardiac assist device that overcomes all shortcomings of current and under development devices and restores patient's quality of life. Its design perfectly fits all the needs of patients suffering from severe heart failure. Implanted inside the left ventricle and synchronized with natural heartbeat, it assists the heart to push blood in a physiological way. T

Status
Closed
Sector
Broadband, Telecommunications
Location
France
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Saving patients from severe heart failure

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Saving patients from severe heart failure” is an infrastructure initiative in the Broadband sector, located in France. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The ICOMS FlowMaker® is the first intracardiac assist device that overcomes all shortcomings of current and under development devices and restores patient's quality of life. Its design perfectly fits all the needs of patients suffering from severe heart failure. Implanted inside the left ventricle and synchronized with natural heartbeat, it assists the heart to push blood in a physiological way. The very low electrical consumption allows for wireless functioning. With no driveline crossing the skin, the risk of infection is suppressed. Without bypass to aorta and thanks to its pulsatile mode, the risk of bleeding is very low. The ICOMS FlowMaker® addresses the market of severe heart failure, where 95% of patients are left without any solution. The aim of the project is to conduct the clinical trials to enter the EU market in 2026, then the US market, allowing to finally achieve EU sovereignty in severe heart failure treatment.

Location

Country

France

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Broadband, Telecommunications

Article published date

2025-11-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project